伦诺克斯-加斯托综合征的精密治疗方法:针对发育和性脑病变的分子病理生理学
1Division of Child Neurology, University of Arkansas for Medical Sciences, Little Rock, AR 72202, USA.
Children (Basel, Switzerland)
|May 1, 2025
概括
伦诺克斯-加斯托综合征 (LGS) 治疗正在从症状管理转向针对特定分子原因的精密治疗. 使用这些新方法的早期干预可以改善控制和预防疾病的进展.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 是一个遗传学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 伦诺克斯-加斯托综合征 (LGS) 是一种严重的儿童,具有耐药性和认知障碍.
- 目前的治疗方法可以控制症状,但不能解决潜在的原因或改善认知结果.
- 在30%-40%的LGS病例中发现了基因,这为精准医学铺平了道路.
研究的目的:
- 根据分子病理生理学,审查LGS的精确治疗策略.
- 探索针对特定遗传和分子途径的新兴疾病修饰治疗方法.
- 讨论LGS研究和治疗的未来方向.
主要方法:
- 科学文献的叙述性审查.
- 探索LGS病理生理学,包括通道病变,受体功能障碍,细胞信号传递,突触病变和表观遗传失调.
- 讨论各种治疗方法,从传统的抗发作药物到基因疗法.
主要成果:
- 针对分子机制的精密治疗方法对LGS有希望.
- 确定的分子标包括特定的基因 (例如SCN2A,STXBP1),途径 (例如mTOR) 和疾病 (例如CDKL5缺乏).
- 新兴的治疗方法包括向药物治疗,基因疗法和重新定位的药物.
结论:
- 精准医学在LGS中提供了一个从症状管理到疾病修饰的范式转变.
- 使用向治疗的早期干预可以改善控制和认知结果.
- 未来的努力应集中在诊断,分组,药物开发,基因疗法和公平获取上.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
272
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
272
Antiepileptic Drugs: Glutamate Antagonists
258
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
258
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
196
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
196
Antiepileptic Drugs: Potassium Channel Activators
134
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
134
Ligand-Gated Ion Channel Receptor: Gating Mechanism
2.0K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
2.0K


